These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27821098)

  • 1. Frequency of Her2/neu expression in colorectal adenocarcinoma: a study from developing South Asian Country.
    Shabbir A; Mirza T; Khalid AB; Qureshi MA; Asim SA
    BMC Cancer; 2016 Nov; 16(1):855. PubMed ID: 27821098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric adenocarcinoma expressing human epidermal growth factor receptor in South Asian population.
    Shabbir A; Qureshi MA; Khalid AB; Mirza T; Shaikh A; Hasan SM
    Saudi J Gastroenterol; 2018; 24(5):289-293. PubMed ID: 29806596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of HER2/neu overexpression in adenocarcinoma of the gastrointestinal system.
    Farzand S; Siddique T; Saba K; Bukhari MH
    World J Gastroenterol; 2014 May; 20(19):5889-96. PubMed ID: 24914350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic significance of EGFR and Her-2/neu in colorectal adenocarcinomas.
    Kountourakis P; Pavlakis K; Psyrri A; Rontogianni D; Xiros N; Patsouris E; Pectasides D; Economopoulos T
    Cancer J; 2006; 12(3):229-36. PubMed ID: 16803682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?
    Kavanagh DO; Chambers G; O'Grady L; Barry KM; Waldron RP; Bennani F; Eustace PW; Tobbia I
    BMC Cancer; 2009 Jan; 9():1. PubMed ID: 19118499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Human Epidermal Growth Factor Receptor (Her 2/neu) and Proliferative Marker Ki-67: Association with Clinicopathological Parameters in Gallbladder Carcinoma.
    Pujani M; Makker I; Makker A; Jetley S; Goel MM; Jetley S
    Asian Pac J Cancer Prev; 2016; 17(8):3903-9. PubMed ID: 27644637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological relevance of HER2/neu and a related gene-protein cubic regression correlation in colorectal adenocarcinomas in Taiwan.
    Li JW; Chuang TC; Yang AH; Hsu CK; Kao MC
    Int J Oncol; 2005 Apr; 26(4):933-43. PubMed ID: 15753987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Her-2/neu over-expression correlates with more advanced disease in Iranian colorectal cancer patients.
    Tavangar SM; Shariftabrizi A; Soroush AR
    Med Sci Monit; 2005 Mar; 11(3):CR123-6. PubMed ID: 15735564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of
    Pandey I; Misra V; Pandey AT; Verma A
    Indian J Pathol Microbiol; 2022; 65(1):35-41. PubMed ID: 35074963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of invariant chain (Ii) and Her-2/neu expression in curatively resected colorectal cancer.
    Rossi HA; Liu Q; Banner B; Hsieh CC; Savas L; Savarese D
    Cancer J; 2002; 8(3):268-75. PubMed ID: 12074327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between Her2/neu status in colorectal carcinoma and clinicopathological features: a retrospective study using whole - tissue sections.
    Kılıçarslan A; Dogan HT; Süngü N; Dogan M; Yalcin A; Dede DŞ
    Pol J Pathol; 2018; 69(2):143-149. PubMed ID: 30351861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HER 2/neu protein expression in colorectal cancer.
    Schuell B; Gruenberger T; Scheithauer W; Zielinski Ch; Wrba F
    BMC Cancer; 2006 May; 6():123. PubMed ID: 16681853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical role of HER-2/neu expression in colorectal cancer.
    Pappas A; Lagoudianakis E; Seretis C; Tsiambas E; Koronakis N; Toutouzas K; Katergiannakis V; Manouras A
    J BUON; 2013; 18(1):98-104. PubMed ID: 23613394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HER-2/neu overexpression is an independent prognostic factor in colorectal cancer.
    Park DI; Kang MS; Oh SJ; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI; Han WK; Kim H; Ryu SH; Sepulveda AR
    Int J Colorectal Dis; 2007 May; 22(5):491-7. PubMed ID: 16947041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Her-2/neu, p-53, and their coexpression in osteosarcoma.
    Bakhshi S; Gupta A; Sharma MC; Khan SA; Rastogi S
    J Pediatr Hematol Oncol; 2009 Apr; 31(4):245-51. PubMed ID: 19346874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration in key oncoprotein expression in gastric adenocarcinoma - An immunohistochemical study.
    Jain P; Wadhwa N; Diwaker P; Joshi MK; Mishra K
    J Cancer Res Ther; 2023 Apr; 19(Supplement):S0. PubMed ID: 37147954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of p185(HER-2/neu) correlates with the stage of disease and survival in colorectal cancer.
    Kapitanović S; Radosević S; Kapitanović M; Andelinović S; Ferencić Z; Tavassoli M; Primorać D; Sonicki Z; Spaventi S; Pavelic K; Spaventi R
    Gastroenterology; 1997 Apr; 112(4):1103-13. PubMed ID: 9097992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of HER-2/neu overexpression in gastric carcinoma using a tissue microarray.
    Rakhshani N; Kalantari E; Bakhti H; Sohrabi MR; Mehrazma M
    Asian Pac J Cancer Prev; 2014; 15(18):7597-602. PubMed ID: 25292034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogenous high-level HER-2 amplification in a small subset of colorectal cancers.
    Marx AH; Burandt EC; Choschzick M; Simon R; Yekebas E; Kaifi JT; Mirlacher M; Atanackovic D; Bokemeyer C; Fiedler W; Terracciano L; Sauter G; Izbicki JR
    Hum Pathol; 2010 Nov; 41(11):1577-85. PubMed ID: 20656317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical detection of Her-2/neu overexpression in breast carcinoma in Nigerians: a 5-year retrospective study.
    Ugiagbe EE; Olu-Eddo AN; Obaseki DE
    Niger J Clin Pract; 2011; 14(3):332-7. PubMed ID: 22037080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.